IM Cannabis Corp. Files 6-K Report
Ticker: IMCC · Form: 6-K · Filed: 2025-05-28T00:00:00.000Z
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
IM Cannabis Corp. filed a 6-K, confirming its foreign private issuer status and 20-F annual report filings.
AI Summary
IM Cannabis Corp. filed a Form 6-K on May 28, 2025, reporting as a foreign private issuer. The filing indicates the company is subject to the reporting requirements of the Securities Exchange Act of 1934 and will file annual reports on Form 20-F. The company's principal executive offices are located in Kibbutz Glil Yam, Israel.
Why It Matters
This filing provides an update on IM Cannabis Corp.'s regulatory status and reporting obligations as a foreign private issuer, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine procedural report and does not contain new financial or operational information that would typically indicate a change in risk.
Key Numbers
- 001-40065 — Commission File Number (Identifies the specific SEC filing record for IM Cannabis Corp.)
Key Players & Entities
- IM Cannabis Corp. (company) — Registrant
- 001-40065 (dollar_amount) — Commission File Number
- 20250528 (date) — Filing Date
- Kibbutz Glil Yam, Israel (location) — Principal Executive Offices
FAQ
What type of report is IM Cannabis Corp. filing?
IM Cannabis Corp. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date of this Form 6-K?
The Form 6-K was filed on May 28, 2025.
Where are IM Cannabis Corp.'s principal executive offices located?
IM Cannabis Corp.'s principal executive offices are located in Kibbutz Glil Yam, Central District, Israel.
Does IM Cannabis Corp. file annual reports on Form 20-F or 40-F?
IM Cannabis Corp. indicated that it files annual reports under cover of Form 20-F.
What is the Commission File Number for IM Cannabis Corp.?
The Commission File Number for IM Cannabis Corp. is 001-40065.
From the Filing
0001178913-25-001983.txt : 20250528 0001178913-25-001983.hdr.sgml : 20250528 20250528081412 ACCESSION NUMBER: 0001178913-25-001983 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250528 FILED AS OF DATE: 20250528 DATE AS OF CHANGE: 20250528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25991217 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533287.htm 6-K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of May 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒    Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date: May 28, 2025 By: /s/ Oren Shuster   Name: Oren Shuster   Title: Chief Executive Officer and Director   EXHIBIT INDEX   99.1 News Release dated May 28, 2025             EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange   TORONTO and GLIL YAM, Israel, May 28, 2025 /CNW/ -- IM Cannabis Corp. (the “ Company ” or “ IMC ”) (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares (“ Shares ”) from the Canadian Securities Exchange (the “ CSE ”). The delisting from the CSE will not affect the Company’s listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol “IMCC”.   The Company is entertaining potential transactions that, if completed while the Company is listed on the CSE, would require the Co